title: Reply to Scahill: Behavioral outcome measures in autism.
authors.affiliation: Department of Pharmacology and Molecular Sciences, Lewis B. and Dorothy Cullman Chemoprotection Center, The Johns Hopkins School of Medicine, Baltimore, MD 21205; and ptalalay@jhmi.edu Andrew.Zimmerman@umassmemorial.org.
authors.forename: Paul
authors.initials: P
authors.lastname: Talalay
authors.affiliation: Department of Pediatrics (Neurology), University of Massachusetts Medical School, Worcester, MA 01655 ptalalay@jhmi.edu Andrew.Zimmerman@umassmemorial.org.
authors.forename: Andrew W
authors.initials: AW
authors.lastname: Zimmerman
mesh_terms: D002659:Child Development Disorders, Pervasive / Q000188:drug therapy*; D006801:Humans; D017879:Isothiocyanates / Q000627:therapeutic use*; D008297:Male
chemical_list: D017879:Isothiocyanates